Search Orphan Drug Designations and Approvals
-
Generic Name: | PEG-b-PLA micelles containing (1) paclitaxel, (2) sirolimus (rapamycin) and (3) tanespimycin (17-AAG)(also known as: triolimus) |
---|---|
Date Designated: | 04/02/2015 |
Orphan Designation: | Treatment of angiosarcoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Co-D Therapeutics, Inc. 1625 Kings Mill Way Suite 205 Madison, Wisconsin 53718 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-